How George Topping Is Profiting from Copper Price Volatility
Source: Brian Sylvester of The Metals Report  (5/21/13)
Everything you thought you knew about copper is wrong. Is it an economic barometer? Nope. Do copper warehouses decrease volatility? Hardly. Can investors play small-cap base metals producers for profit? You bet. These are the conclusions Analyst George Topping shared with us in his interview with The Metals Report. Find out why Doctor Copper just might be stripped of its credentials and whether you should trade in your gold for platinum group metals. More >

Investors Versus Traders: A Battle for Oil & Gas Profits
Source: Zig Lambo of The Energy Report  (5/21/13)
The worst may be over for companies and investors who have weathered the depressed gas prices of the past few years, but that doesn't mean it's clear sailing from here. In this interview with The Energy Report, Robert Cooper, senior energy analyst with Haywood Securities, talks about the need for selectivity and patience for catalysts that can crystallize underlying stock values. It's a battle of long-term investors versus short-term traders. More >

6 Reasons Why Gold Stocks Will Begin a Huge Rally
Source: Jordan Roy-Byrne, The Daily Gold  (5/21/13)
It's been a tough road for precious metals but the path ahead has strong potential of being significantly profitable compared to these levels. More >

Natural Gas Companies Inch Closer to LNG Export Approvals
Source: Tony Daltorio, Money Morning  (5/21/13)
"The Obama administration gave the thumbs up (a 20-year approval) to the Freeport LNG project in Texas." More >

Brent Cook's Primer on Reading Drill Result Press Releases
Source: JT Long of The Gold Report  (5/20/13)
"Half science, half art, half luck," is how Brent Cook describes a geologist's work in distinguishing an anomaly from a deposit. But in his interview with The Gold Report,
the publisher of Exploration Insights suggests investors will have an easier time distinguishing good drill results from bad if they know how to dissect a company's press releases. And despite the current preference for cost cutting over discovery, Cook discusses several miners whose futures are bright.
More >

Volatility in Precious Metals Driven by Investor Switch from Commodities to Equities
Source: Adrian Ash, BullionVault  (5/20/13)
"Initially extending Friday's late drop to touch $1,340/oz for only the second time since January 2011, gold rallied from new five-week lows for euro and British pound investors." More >

Salmon Sperm May Provide Cheap Option for Rare Earths Recovery
Source: Dorothy Kosich, Mineweb  (5/20/13)
"Dried salmon milt or sperm is a low-cost and environment-friendly method to extract rare earth metals." More >

The Resurgence of the Nuclear Reactor
Source: Casey Energy Team  (5/20/13)
"An energy opportunity that could boost your net worth 500%—or more." More >

Biotechnology ETF Investing 101
Source: Zacks Equity Research  (5/20/13)
"The sector maintained its strong performance in 2013 as generic competition is forcing many Pharma companies to engage in merger and acquisition deals." More >

Caesars Report's Second Most Important Factor in Picking a Winning Mining Investment: Jurisdiction
Source: Brian Sylvester of The Gold Report  (5/17/13)
Jurisdiction risk continues to grow as a result of countries attempting to capitalize on higher commodity prices. In this interview for The Gold Report,Thibaut Lepouttre, editor of Caesars Report, a newsletter and mining portal in Belgium, discusses which jurisdictions offer better value to investors and which countries to avoid. He also offers suggestions on where to look outside of North America for compelling values in junior mining. More >

Two Biotech Ideas You May Have Missed: William Gregozeski
Source: George S. Mack of The Life Sciences Report   (5/16/13)
Adventurous investors have long sought out micro-cap stocks, attracted by the profit potential of starting on the bottom floor and rocketing toward blue sky. Biotechnology can add even more power to the upside possibilities of micro caps, especially now that pharma is starved for new products and will pay well for solid ideas. Managing partner William Gregozeski of Mont Blanc Capital Management has focused on very small, unnoticed stocks for most of his career and has pegged two undiscovered biotechs that could break out to big-time valuations. In this interview with The Life Sciences Report, Gregozeski elaborates on the stories behind these two investment opportunities. More >

Junior Gold Producers' Q1/13 Earnings Show Profitability
Source: Kip Keen, Mineweb  (5/16/13)
"Junior gold producers are still, by and large, not in a panic about the current price of gold, though for some it puts the pressure on." More >

Gold and Bitcoin: Currencies of the Future—James Turk
Source: JT Long of The Gold Report  (5/15/13)
Europe, says James Turk, founder and chairman of GoldMoney, is in the midst of two crises—one in the banking sector, the other related to economic activity, and capital is needed to solve both. As to the allegedly strong dollar, Turk, in this interview with The Gold Report, suggests comparing it to the price of gold rather than other fiat currencies for a better picture. And the world's newest currency—Bitcoin—has a lot in common with one of the oldest—gold. More >

The Hottest North American Shale Plays: Josh Young
Source: Alec Gimurtu of The Energy Report  (5/15/13)
Not all shale plays are created equal, and one in particular is bucking the trend with robust economics and company share prices that show it. But is it too late to buy in? Fund Manager Josh Young doesn't think so, and he sat down with The Energy Report to discuss the hottest (and coldest) North American shale plays. Read on to find out where he's finding bargains that could pay off handsomely. More >

Daren Oddenino: How to Spot Oil and Gas Takeout Targets
Source: Tom Armistead of The Energy Report  (5/14/13)
Let's make one thing clear: There is no magic formula to determine which company will be the next big buyout story. But if there were a formula, it would include variables like asset value, management skill level, risk profile and location, location, location. Today, C. K. Cooper & Co. Analyst Daren Oddenino joins The Energy Report to discuss M&A trends and help us solve for X. One caveat—a company that tempts an international player might leave domestic majors cold. More >

Tips for Diversifying Beyond Gold from Brent Cook
Source: JT Long of The Metals Report  (5/14/13)
Last month's landslide at Utah's Bingham Canyon, one of the world's largest copper mines, triggered significant discussion on possible copper shortages. Brent Cook, veteran geologist and publisher of Exploration Insights, puts the landslide into perspective in this interview with The Metals Report. And for investors who want to dig out profit potential beyond the yellow metal, Cook gives us a byproduct primer and suggests base metals are a great way to diversify. More >

Marin Katusa: Time to Invest in Uranium
Source: Vivien Diniz, Uranium Investing News  (5/14/13)
"Marin Katusa believes uranium is the most contrarian resource investment today." More >

Why Peter Grandich Is Still Telling His Wife Gold Will Hit $2,000/oz
Source: Brian Sylvester of The Gold Report  (5/13/13)
Many junior mining investors have run off with their tails between their legs. And who can blame them when even the portfolios of market veterans like Peter Grandich, publisher and editor of The Grandich Letter, have taken a beating? But before you cash in, you might want to read why Grandich still has hope for $2,000/oz gold, and which companies he believes have the mojo to make it through this trough in this interview with The Gold Report. More >

US Silver Production Up 17% in February 2013: USGS
Source: Dorothy Kosich, Mineweb   (5/13/13)
"Combined U.S. mining silver production for January and February of this year was 183,000 kg (5,883,586 oz), said the USGS." More >

A Total Overhaul of the Global Oil Patch
Source: Byron King, The Daily Reckoning  (5/13/13)
"Can energy exporters just turn the valves, lower output and ship out less oil in order to goose up the price? Not likely." More >

Three Reasons to Buy Gold Equities Today
Source: Frank Holmes, Frank Talk  (5/13/13)
"I believe the drivers for the yellow metal remain intact, so for investors who can tolerate the ups and downs, gold stocks are a compelling buy." More >

Precious Metal Royalties: The New Landscape
Source: JF Gunter of The Gold Report  (5/10/13)
In today's challenging finance environment, some miners are looking to royalty companies to fill the funding void. Royalty sales give the junior mining company capital to explore or build a mine in exchange for a percentage of future production. It is a win-win. Investors have exposure to gold profits, but are immune to much of the risk. Juniors get the money they need to move forward. But not all royalties are the same and a number of new types have entered the market to fill specific investing and funding niches. In this special primer from The Gold Report, we survey the heads of the companies to explain the role they see themselves playing in investment portfolios and the future of mining. More >

Placing Bets on Colombia: Paul Harris
Source: Brian Sylvester of The Gold Report  (5/10/13)
Some exploration projects in Colombia are advancing to the mine definition stage, says Paul Harris, the Colombia-based editor and publisher of the Colombia Gold Letter, and with the government starting to provide the level of administration that the sector needs, the country is poised for great things. In this interview with The Gold Report,
Harris discusses the implications of Colombia's 2001 mining code and which companies are leading the project development curve.
More >

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert
Source: George S. Mack of The Life Sciences Report  (5/10/13)
Stem cell companies have languished long enough in micro-cap territory. The industry is now approaching highly visible phase 2 and phase 3 catalysts that will produce results never before seen in medicine. Managing Director and Senior Biotechnology Analyst Jason Kolbert of the Maxim Group has staked out a select group of nascent cell therapy companies positioned to reap huge gains for investors willing to diversify. In this interview with The Life Sciences Report, Kolbert reflects on the regenerative medicine space following the recent RegenMed Investor Day conference, and makes an enthusiastic case for his very best ideas. More >

Takeaway for Biotech Investors: Keep Targeted Cancer Immunotherapies in Mind
Source: Ray Blanco, The Daily Reckoning  (5/10/13)
"Increasingly, the great new medical technologies aren't coming from the pharmaceutical behemoths, but from scrappy little biotech upstarts. In few instances is this truer than in the field of cancer immunotherapy." More >